Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion

BACKGROUND: Two treatments, ranibizumab and dexamethasone implant, for visual impairment due to macular oedema (ME) secondary to retinal vein occlusion (RVO) have recently been studied in clinical trials. There have been no head to head comparisons of the two treatments, and improvement measured as...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Med Res Methodol
Egile Nagusiak: Thom, Howard HZ, Capkun, Gorana, Nixon, Richard M, Ferreira, Alberto
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289570/
https://ncbi.nlm.nih.gov/pubmed/25533265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2288-14-140
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak